Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine plus ACE inhibitor versus ACE inhibitor alone for blood pressure control in hypertension
IRCT2014022616750N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in hypertension (HTN) (2 arms), sponsored by Shahrekord University of Medical Sciences. Started Mar 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT2014022616750N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014022616750N1.